Advanced search
Publication Cover
Leukemia & Lymphoma Volume 39, 2000 - Issue 1-2
Submit an article Journal homepage
33
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Intensive Chemotherapy (LNHIV-91 Regimen) and G-CSF for HIV Associated Non-Hodgkin's Lymphoma

Eric Oksenhendler Department of Immunology and Hematology, Hôpital St Louis, Paris
,
Laurence Gerard Department of Immunology and Hematology, Hôpital St Louis, Paris
,
Marie-Laure Dubreuil Department of Clinical Immunology, Hôpital Henri Mondor, Créteil
,
Yves Levy Department of Clinical Immunology, Hôpital Henri Mondor, Créteil
,
Sophie Matheron Department of Infectious Diseases, Hôpital Bichat-Claude Bernard, Paris, France
,
Dominique Cazals-Hatem Department of Pathology, Hôpital St Louis, Paris
,
Sylvie Chevret Department of Biostatistics, Hôpital St Louis, Paris
&
Jean-Pierre Clauvel Department of Immunology and Hematology, Hôpital St Louis, Paris
 show all
Pages 87-95 | Received 26 Jan 2000, Published online: 01 Jul 2009

References

  • Ziegler JL, Beckstead JA, Volberding PA. Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. New England Journal of Medicine 1984; 311: 565–570
  • Levine A. Acquired Immunodeficiency Syndrome-Related Lymphoma. Blood 1992; 80: 8–20
  • Gill PS, Levine AM, Krailo M. AIDS-related malignant lymphoma: results of prospective treatment trials. Journal of Clinical Oncology 1987; 5: 1322–1328
  • Kaplan LD, Abrams DI, Feigal E. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261: 719–724
  • Bermudez M, Grant KM, Rodvien R Mendes. Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: Indications for intensive chemotherapy. American Journal of Medicine 1989; 86: 71–76
  • Levine AM, Werz JC, Kaplan L. Low dose chemotherapy with central nervous system prophylaxis and azidothymidine maintenance in AIDS-related lymphoma: A prospective multi-institutional trial. JAMA 1991; 266: 84–88
  • Kaplan LD, Strauss DJ, Testa MA. Low-dose compared with standard-dose m-BACOD chemotherapy for non-hodgkin's lymphoma associated with human immunodeficiency virus infection. New England Journal of Medicine 1997; 336: 1641–1648
  • Levine AM, Sullivan-Halley J, Pike MC. Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival. Cancer 1991; 68: 2466–2472
  • Gisselbrecht C., Oksenhendler E, Tirelli U. Human immunodeficiency virus-related lymphoma: Treatment with intensive combination chemotherapy. American Journal of Medicine 1993; 95: 188–196
  • Kaplan LD, Kahn JO, Crowe S. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: Results of a randomized trial. Journal of Clinical Oncology 1991; 9: 929–940
  • Walsh C., Wernz JC, Levine A. Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. Journal of the Acquired Immunodeficiency Syndrome 1993; 6: 265–271
  • Hryniuk W, Bush H. The importance of dose intensity in chemotherapy of metastatic breast cancer. Journal of Clinical Oncology 1984; 2: 1281–1288
  • Centers for Diseases Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity Mortality Weekly Report 1992; 41: 1–19
  • Gordon LI, Harrington D, Andersen J. Comparison of a second-generation chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. New England Journal of Medicine 1992; 327: 1342–1349
  • Fisher RI, Gaynor ER, Dahlberg S. Comparison of a standard (CHOP) regimen with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine 1993; 328: 1002–1006
  • Coiffier B, Gisselbrecht C., Herbrecht R. LNH84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. Journal of Clinical Oncology 1989; 7: 1018–1026
  • Sparano JA, Wiernik PH, Strack M, Leaf A, Becker N, Valentine S. Infusional Cyclophosphamide, Doxorubicin and Etoposide in human immunodeficiency virus-and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: A highly active regimen. Blood 1993; 81: 2810–2815

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.